Cargando…
Epicardially Placed Bioengineered Cardiomyocyte Xenograft in Immune-Competent Rat Model of Heart Failure
BACKGROUND: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are under preclinical investigation as a cell-based therapy for heart failure post-myocardial infarction. In a previous study, tissue-engineered cardiac grafts were found to improve hosts' cardiac electrical and...
Autores principales: | Chinyere, Ikeotunye Royal, Bradley, Pierce, Uhlorn, Joshua, Eason, Joshua, Mohran, Saffie, Repetti, Giuliana G., Daugherty, Sherry, Koevary, Jen Watson, Goldman, Steven, Lancaster, Jordan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325579/ https://www.ncbi.nlm.nih.gov/pubmed/34341667 http://dx.doi.org/10.1155/2021/9935679 |
Ejemplares similares
-
Surgical treatment for heart failure: cell-based therapy with engineered tissue
por: Lancaster, Jordan J., et al.
Publicado: (2019) -
Free-breathing gradient recalled echo-based CMR in a swine heart failure model
por: Morris, Craig C., et al.
Publicado: (2022) -
Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts
por: Lancaster, J. J., et al.
Publicado: (2023) -
Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Sun, Xuetao, et al.
Publicado: (2017) -
Bioengineering Methods in MicroRNA-Mediated Direct Reprogramming of Fibroblasts Into Cardiomyocytes
por: Paoletti, Camilla, et al.
Publicado: (2021)